Aspect Biosystems Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 107

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $72.8M

  • Investors
  • 34

Aspect Biosystems General Information

Description

Developer of a full-stack tissue therapeutic platform designed to innovate at the intersection of biology, medicine, and engineering to build living human tissues. The company's platform offers proprietary microfluidic 3D bioprinting technology that creates advances in understanding fundamental biology, disease research, development of novel therapeutics, and regenerative medicine, enabling researchers to understand the creation of human tissues for medical research, therapeutic discovery, and medicine products.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Corporate Office
  • 887 Great Northern Way
  • Suite 500
  • Vancouver, British Columbia V5T 4T5
  • Canada
+1 (604) 000-0000

Aspect Biosystems Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aspect Biosystems Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Grant 10-Jul-2024 $72.8M 000.00 Completed Generating Revenue
13. Accelerator/Incubator 000.00 Completed Generating Revenue
12. Later Stage VC 12-Apr-2023 0000 000.00 Completed Generating Revenue
11. Grant 20-Mar-2023 00.00 000.00 Completed Generating Revenue
10. Secondary Transaction - Private 000.00 Completed Generating Revenue
9. Later Stage VC (Series A) 01-Jun-2020 0000 000.00 Completed Generating Revenue
8. Grant 15-Nov-2018 00.00 00000 Completed Generating Revenue
7. Later Stage VC 15-Mar-2018 00000 00000 Completed Generating Revenue
6. Early Stage VC 31-Jul-2017 Completed Generating Revenue
5. Seed Round 01-Oct-2016 Completed Generating Revenue
To view Aspect Biosystems’s complete valuation and funding history, request access »

Aspect Biosystems Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a full-stack tissue therapeutic platform designed to innovate at the intersection of biology, medicine, and
Biotechnology
Vancouver, Canada
107 As of 2024
000.00
0000000000 000.00

000000

na aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris ni
0000000000000
Villaz-Saint-Pierre, Switzerland
00 As of 0000
000000000000

000000

m ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incid
0000000000000
Schlieren, Switzerland
00 As of 0000
000.00
00000 0000-00-00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Aspect Biosystems Competitors (9)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
REGENHU Venture Capital-Backed Villaz-Saint-Pierre, Switzerland 00 000000000000
InSphero Venture Capital-Backed Schlieren, Switzerland 00 000.00 0000000000 0 000.00
Cerapedics Venture Capital-Backed Westminster, CO 000 00000 000000000 00000
Organovo Formerly VC-backed San Diego, CA 00 0000 00000000 0000
Synthecon Accelerator/Incubator Backed Houston, TX 00 0000000000
You’re viewing 5 of 9 competitors. Get the full list »

Aspect Biosystems Patents

Aspect Biosystems Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2022408220-A1 Radial pump assembly and methods of using same Pending 16-Dec-2021 0000000000
CA-3241238-A1 Radial pump assembly and methods of using same Pending 16-Dec-2021 0000000000
CA-3230168-A1 Microfluidic-based fiber formation methods and systems Pending 27-Aug-2021 0000000000
AU-2022332665-A1 Microfluidic-based fiber formation methods and systems Pending 27-Aug-2021 0000000000
EP-4392747-A1 Microfluidic-based fiber formation methods and systems Pending 27-Aug-2021 B29C64/393
To view Aspect Biosystems’s complete patent history, request access »

Aspect Biosystems Executive Team (15)

Name Title Board Seat Contact Info
Tamer Mohamed Co-Founder, Chief Executive Officer, President and Board Member
Raymond Smith Chief Financial Officer
Simon Beyer Ph.D Chief Technology Officer
Samuel Wadsworth Ph.D Co-Founder & Chief Scientific Officer
Eric Roos Chief Business Development Officer
You’re viewing 5 of 15 executive team members. Get the full list »

Aspect Biosystems Board Members (8)

Name Representing Role Since
Andrew Haughian Pangaea Ventures Board Member 000 0000
Christopher Bissonnette Ph.D Pallasite Ventures Board Member 000 0000
Devyn Smith Ph.D Self Board Member 000 0000
Donald Haut Ph.D Self Board Member 000 0000
Konrad Walus Ph.D Aspect Biosystems Co-Founder & Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Aspect Biosystems Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aspect Biosystems Investors (34)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
British Columbia Ministry of Economic Development Government 000 0000 000000 0
Novo Nordisk Corporation 000 0000 000000 0
Government of Canada Government 000 0000 000000 0
Cascadia Venture Forum Venture Capital Minority 000 0000 000000 0
Darcy Hughes Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 34 investors. Get the full list »

Aspect Biosystems FAQs

  • When was Aspect Biosystems founded?

    Aspect Biosystems was founded in 2013.

  • Who is the founder of Aspect Biosystems?

    Tamer Mohamed, Simon Beyer Ph.D, Samuel Wadsworth Ph.D, and Konrad Walus Ph.D are the founders of Aspect Biosystems.

  • Who is the CEO of Aspect Biosystems?

    Tamer Mohamed is the CEO of Aspect Biosystems.

  • Where is Aspect Biosystems headquartered?

    Aspect Biosystems is headquartered in Vancouver, Canada.

  • What is the size of Aspect Biosystems?

    Aspect Biosystems has 107 total employees.

  • What industry is Aspect Biosystems in?

    Aspect Biosystems’s primary industry is Biotechnology.

  • Is Aspect Biosystems a private or public company?

    Aspect Biosystems is a Private company.

  • What is Aspect Biosystems’s current revenue?

    The current revenue for Aspect Biosystems is 000000.

  • How much funding has Aspect Biosystems raised over time?

    Aspect Biosystems has raised $95.8M.

  • Who are Aspect Biosystems’s investors?

    British Columbia Ministry of Economic Development, Novo Nordisk, Government of Canada, Cascadia Venture Forum, and Darcy Hughes are 5 of 34 investors who have invested in Aspect Biosystems.

  • Who are Aspect Biosystems’s competitors?

    REGENHU, InSphero, Cerapedics, Organovo, and Synthecon are some of the 9 competitors of Aspect Biosystems.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »